BioSpace News Archive

Genetown

Seaport Therapeutics Presents Data from Multiple SPT-300 Trials at Society of Biological Psychiatry (SOBP) Annual Meeting

Seaport Therapeutics, a clinical-stage biopharmaceutical company that is charting a proven path in neuropsychiatry, announced two poster presentations detailing the results from multiple clinical trials of SPT-300 at the Society of Biological Psychiatry Annual Meeting in Austin, TX.

May 9, 2024
·
7 min read
Business

LENSAR Reports First Quarter 2024 Results and Provides Business Update

LENSAR, Inc. today announced financial results for the quarter ended March 31, 2024 and provided an update on key operational initiatives.

May 9, 2024
·
13 min read
Genetown

Bruker Corporation to Host Investor Webinar on May 17, 2024

Bruker Corporation (Nasdaq: BRKR) today announced it intends to hold an Investor Webinar from 10 am to about 12 noon Eastern Daylight Time (EDT) on May 17, 2024, to provide additional insights into its three recent acquisitions of Chemspeed, ELITech, and of the NanoString business.

May 9, 2024
·
1 min read
ADC Therapeutics to Participate in 2024 RBC Capital Markets Global Healthcare Conference

ADC Therapeutics SA (NYSE: ADCT) today announced that Ameet Mallik, Chief Executive Officer, will participate in a fireside chat at the 2024 RBC Capital Markets Global Healthcare Conference on Tuesday, May 14, 2024, at 1:35 p.m. ET.

May 9, 2024
·
4 min read
Business

Verona Pharma Reports First Quarter 2024 Financial Results and Provides Corporate Update

Verona Pharma plc announces its financial results for the first quarter ended March 31, 2024.

May 9, 2024
·
14 min read
Genetown

PureTech Founded Entity Seaport Therapeutics Presents Data from Multiple SPT-300 Trials at Society of Biological Psychiatry (SOBP) Annual Meeting

PureTech Health plc today announced two poster presentations detailing the results from multiple clinical trials of SPT-300 at the Society of Biological Psychiatry Annual Meeting in Austin, TX.

May 9, 2024
·
10 min read
Business

Charles River Laboratories Announces First-Quarter 2024 Results

Charles River Laboratories International, Inc. (NYSE: CRL) today reported its results for the first quarter of 2024. For the quarter, revenue was $1.01 billion, a decrease of 1.7% from $1.03 billion in the first quarter of 2023.

May 9, 2024
·
29 min read
Biotech Beach

Reflow Medical Completes Enrollment in the DEEPER REVEAL Clinical Trial

Reflow Medical, Inc. , a developer of innovative devices focused on cardiovascular disease, announces completion of enrollment in the DEEPER REVEAL clinical trial (NCT05358353) to evaluate the Reflow Spur™ Stent.

May 9, 2024
·
2 min read
Business

Apyx Medical Corporation Reports First Quarter 2024 Financial Results; Reaffirms Full Year 2024 Financial Outlook

Apyx Medical Corporation today reported financial results for its first quarter ended March 31, 2024; and reaffirmed its financial expectations for the full year ending December 31, 2024.

May 9, 2024
·
13 min read
Lone Star Bio

Lexicon Pharmaceuticals to Participate in the Bank of America Securities Healthcare Conference 2024

Lexicon Pharmaceuticals, Inc. announced its participation in the Bank of America Securities Healthcare Conference 2024. Jeff Wade, Lexicon’s president and chief financial officer, will make a company presentation on Tuesday, May 14, 2024, at 8:00 am PDT.

May 9, 2024
·
2 min read